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Abstract
Background: Although microbiota play a critical role in the normal development and function of
host immune systems, the underlying mechanisms, especially those involved in the large intestine
(LI), remain unknown. In the present study, we performed transcriptome analysis of the LI of germ-
free (GF) and specific pathogen-free (SPF) mice of the IQI strain, an inbred strain established from
ICR mice.
Results: GeneChip analysis, quantitative real-time RT-PCR, and reconfirmation using bacteria-
inoculated GF mice revealed differences in the expression levels of several immune-related genes,
such as cryptdin-related sequences (CRS), certain subsets of type 1 interferon (IFN)-related genes,
class Ib MHC molecules, and certain complements. LI expressed no authentic cryptdins but
predominantly expressed CRS2, 4, and 7. The mRNA levels of IFN-related genes, including Irf7,
Isgf3g, Ifit1 and Stat1, were lower in SPF- and flora-reconstituted mice. When an oral IFN-α inducer
tilorone analog, R11567DA, was administered to SPF mice, IFN-α was induced rapidly in the LI at
4 h, whereas no IFN-α protein was detected in the small intestine (SI) or blood. In situ hybridization
and immunohistochemistry suggested that the IFN-α production originated from Paneth cells in the
SI, and portions of lamina proprial CD11b- or mPDCA1-positive cells in the LI.
Conclusion: The present study suggests that microbial colonization, while inducing the expression
of anti-microbial peptides, results in the down-regulation of certain genes responsible for immune
responses, especially for type I IFN synthesis. This may reflect the adaptation process of the
immune system in the LI to prevent excessive inflammation with respect to continuous microbial
exposure. Further, the repertoire of anti-microbial peptides and the extraordinary role of
interferon producing cells in the LI have been found to be distinct from those in the SI.
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Background
Humans harbor an enormous number of microbes in the
intestine. Intestinal flora have been suggested to play a
critical role in the normal development and physiology of
host animals. Symbiosis of human commensal bacteria
forms a metasystem of nutrient uptake and endobiotic/
xenobiotic metabolism whose capacities greatly exceed
those provided by the products of genes encoded in the
human genome [1]. Further, gut microbiota are a key reg-
ulator of the human immune system. The immune
response must be balanced between defending against
pathogens while at the same time recognizing commen-
sals as harmless [1-3]. The immune system of the small
intestine, which is comprised of a variety of regulatory and
effector compartments including Peyer's Patch cells,
intraepithelial lymphocytes, lamina propria mononuclear
cells and intestinal epithelial cells, has been extensively
documented [4,5]. The normal colon, however, appar-
ently lacks important structures/components such as
Peyer's patches (PP) and Paneth cells, and little is known
about the immunology of the large intestine, despite the
marked differences in both function and luminal environ-
ment between the different regions of the intestine [6,7].
Previous studies using germ-free (GF)-, bacteria-reconsti-
tuted GF-, specific pathogen-free (SPF)- and conventional
(CV)- mice have revealed that enteric bacteria have pro-
found effects on the number and population of immune
cells in PP [4,8,9], differentiation of Paneth cells [10-12],
migration of T cells bearing α/β T cell receptor into the
intestinal epithelium [13], development of IFN-γ-driven
immune function [14,15] such as Th1 skewing [16] and
MHC class II antigen expression [17,18], and oral toler-
ance induction [8,16,19]. Although functional genomics
have demonstrated that enteric bacteria affect the expres-
sion of genes involved in the mucosal barrier and immu-
nological defense [20,21], the mechanisms by which
these immunological changes are induced, especially in
the large intestine, are still obscure.
In the present study, transcriptome analysis was per-
formed on colon tissues from IQI mice, an inbred strain
established from ICR mice [22]. IQI mice are an autoim-
mune-prone strain: they induce a high level of antinuclear
auto-antibody following mercuric chloride treatment
[23], have thymic B cells [24], show age-related develop-
ment of Sjogren's syndrome-like sialadenitis [25], and
exhibit spontaneous skin lesions in aged females [26].
Comparisons of picryl chloride-induced contact dermati-
tis in BALB/c and IQI mice suggested that enhanced anti-
gen presentation capacity in the ear dermis of IQI mice
resulted in prominent T cell infiltration and more severe
dermatitis as compared with BALB/c mice [26,27]. High
sensitivity in the mucosal sites in IQI mice suggests that
this strain may be useful for investigating changes in
mucosa-associated immune systems induced by bacterial
burden. The present results demonstrated that bacterial
colonization increases the expression of cryptdin-like
products and decreases the expression of regulatory fac-
tors that are indispensable prerequisites for massive IFN-
α synthesis. Our investigation of the cells responsible for
these changes by in situ hybridization and time course
analysis of IFN-α production suggested that IFN-α plays
an important role in the defense response in the large
intestine.
Results
GeneChip analysis of the large intestines of GF and SPF 
mice
There were 11 probe sets whose expression levels in SPF
mice were significantly (> 2 fold) higher than in GF mice
(Table 1). Among these 11 probe sets, 6 were those of the
Table 1: Genes more highly expressed in large intestines of SPF mice than those in GF mice
Probe Set ID Gene Name* Gene Symbol Fold Change** p-value
160918_at S100 calcium binding protein G S100 g 10.16 0.006
100351_f_at defensin related cryptdin 3/defensin-related cryptdin 23 Defcr3/Defcr23 5.27 0.049
99551_f_at defensin related cryptdin 5 Defcr5 4.79 0.022
93863_f_at defensin related cryptdin 3/defensin related cryptdin 6/
defensin-related cryptdin 23/defensin-related cryptdin 24
Defcr3/Defcr6/Defcr23/
Defcr24
4.30 0.034
93879_f_at defensin related cryptdin 3 Defcr3 4.00 0.031
92812_f_at defensin related cryptdin 3/defensin related cryptdin 4/
defensin related cryptdin 6/RIKEN cDNA 2010016F14 gene/
defensin-related cryptdin 23/defensin-related cryptdin 24
Defcr3/Defcr4/Defcr6/
2010016F14Rik/Defcr23/
Defcr24
3.67 0.018
160909_at small proline-rich protein 1A Sprr1a 3.64 0.046
100884_at aldo-keto reductase family 1, member B8 Akr1b8 2.89 0.001
102993_at glycoprotein galactosyltransferase alpha 1, 3 Ggta1 2.88 0.016
101794_f_at defensin-related cryptdin 23 Defcr23 2.56 0.034
93755_at resistin like beta Retnlb 2.00 0.015
*The genes of defensin family are shown in bold font.
**Fold change is defined as the ratio of the signal of SPF to that of GF.BMC Genomics 2008, 9:192 http://www.biomedcentral.com/1471-2164/9/192
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cryptdin family. When we applied the same criteria, there
were 43 probe sets expressed at lower levels in SPF mice
than in GF mice (Table 2). The list of decreased genes con-
tains 11 genes whose expression has been reported to be
induced by type-1 interferon. Table 1 lists glycoprotein
galactosyltransferase-alpha 1,3 (Ggta1) and Table 2 lists
Table 2: Genes more highly expressed in large intestines of GF mice than those in SPF mice
Probe Set ID Gene Name Gene Symbol Fold change* p-value
Type 1 interferon-related genes
104750_at interferon gamma inducible protein 47 Ifi47 5.13 0.003
103639_at interferon-induced protein with tetratricopeptide repeats 2 Ifit2 4.87 0.009
102906_at T-cell specific GTPase Tgtp 3.99 0.036
100981_at interferon-induced protein with tetratricopeptide repeats 1 Ifit1 3.81 0.013
103202_at guanylate nucleotide binding protein 4 Gbp4 3.76 0.030
104177_at radical S-adenosyl methionine domain containing 2 Rsad2 3.20 0.006
97409_at immunity-related GTPase family, M Irgm 3.03 0.008
101465_at signal transducer and activator of transcription 1 Stat1 2.63 0.025
104669_at interferon regulatory factor 7 Irf7 2.58 0.022
103335_at lectin, galactose binding, soluble 9 Lgals9 2.26 0.042
104597_at guanylate nucleotide binding protein 2 Gbp2 2.15 0.035
Immunoglobulins
96969_at similar to Ig V-K167 precursor LOC381776 7.39 0.014
93904_f_at similar to Ig H-chain (VDJ-region) precursor LOC238418 6.11 0.023
101320_f_at similar to IgM(b) heavy pre-chain (AA -18 to 119)/similar to 
anti-poly(dC) monoclonal antibody heavy chain/similar to 
immunoglobulin heavy chain/similar to Ig heavy chain V region 
3 precursor/similar to monoclonal antibody heavy chain
V165-D-J-C mu etc 3.87 0.006
93584_at immunoglobulin heavy chain 6 (heavy chain of IgM)/Unknown 
(protein for MGC:60843)
Igh-6/MGC60843 2.57 0.041
97575_f_at Immunoglobulin heavy chain 1a (serum IgG2a), mRNA 
(cDNA clone MGC:6529 IMAGE:2651493)
Igh-VJ558 2.33 0.011
93638_s_at immunoglobulin lambda chain, variable 1 Igl-V1 2.25 0.017
Other molecules
103957_at transferrin receptor Tfrc 6.84 0.001
160986_r_at angiotensin I converting enzyme (peptidyl-dipeptidase A) 2 Ace2 5.13 0.040
92699_at solute carrier family 7 (cationic amino acid transporter, y+ 
system), member 9
Slc7a9 4.45 0.014
96792_at apolipoprotein B Apob 3.60 0.022
160933_at interferon gamma induced GTPase Igtp 3.39 0.003
94936_at meprin 1 beta Mep1b 3.33 0.011
96912_s_at cytotoxic T lymphocyte-associated protein 2 alpha/cytotoxic 
T lymphocyte-associated protein 2 beta
Ctla2a/Ctla2b 3.30 0.000
102373_at glutamyl aminopeptidase Enpep 3.13 0.008
100030_at uridine phosphorylase 1 Upp1 3.10 0.006
98994_at solute carrier family 34 (sodium phosphate), member 2 Slc34a2 3.05 0.012
98410_at interferon inducible GTPase 2 Iigp2 2.91 0.007
92689_at interleukin 18 binding protein Il18bp 2.82 0.021
103025_at Moloney leukemia virus 10 Mov10 2.79 0.035
97950_at xanthine dehydrogenase Xdh 2.74 0.016
102559_at bone morphogenetic protein 2 Bmp2 2.49 0.020
96764_at interferon inducible GTPase 1 Iigp1 2.48 0.001
94088_at polypyrimidine tract binding protein 2 Ptbp2 2.42 0.012
97500_g_at four and a half LIM domains 1 Fhl1 2.32 0.049
98958_at enhancer of yellow 2 homolog (Drosophila) Eny2 2.30 0.021
103250_at deafness, autosomal dominant 5 homolog (human) Dfna5h 2.26 0.042
97994_at transcription factor 7, T-cell specific Tcf7 2.25 0.026
92877_at transforming growth factor, beta induced Tgfbi 2.23 0.023
102965_at expressed sequence AI481105 AI481105 2.17 0.019
104606_at CD52 antigen Cd52 2.15 0.004
99463_at cytochrome P450, family 3, subfamily a, polypeptide 13 Cyp3a13 2.14 0.011
99993_at alanyl (membrane) aminopeptidase Anpep 2.08 0.017
* Fold change is defined as the ratio of the signal of GF to that of SPF.BMC Genomics 2008, 9:192 http://www.biomedcentral.com/1471-2164/9/192
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Ifit1/GARG16, and four and a half LIM domains 1 (Fhl1),
which have been noted to change in SPF mice or colo-
nized GF mice in previous reports [20,28]. However, there
are only a few additional genes, whose function is consid-
ered to be "professionally" immune-related.
Verification of the changes in gene expression by RT-PCR
We next attempted to confirm the GeneChip data by using
quantitative real time RT-PCR. Because the cryptdin fam-
ily consists of more than 20 genes with DNA sequences of
extraordinarily high homology, we determined the gene
identity by DNA sequencing. The RT-PCR fragments
amplified using the primers common for the cryptdin
family were cloned into pT7Blue vector. DNA sequencing
has suggested that the members of cryptdin family pre-
dominantly expressed in the colon of IQI GF and SPF
mice are all cryptdin-related sequences; i.e. Defcr-rs 4, 2,
and 7 (40, 7, 10 of GF mice-derived 62 clones and 24, 15,
16 of SPF-mice derived 61 clones, respectively). No
authentic cryptdins were found among the sequences of
the aforementioned 123 clones. Because of the difficulties
in designing the primer/probe sets, due to extremely high
sequence homology among these genes, further investiga-
tion using quantitative RT-PCR has not been done.
When we extended the criteria to genes with a greater than
1.5-fold ratio of expression in GF mice as compared with
SPF mice, an additional class of immune-related genes
were identified; namely, complement-related genes and
MHC-related genes. The latter contains non-classical
MHC class 1b genes which are known to be monomor-
phic or oligomorphic and expressed in a limited number
of tissues, such as thymus and intestinal epithelium
[29,30]. Furthermore, MHC I genes are known to be type
1 IFN-inducible genes whose promoter regions contain
typical interferon stimulus response elements (ISREs)
[31,32]. In addition to the immune-related genes listed in
Table 2, additional genes (for example, several interferon
regulatory factors, IFN-α-inducible genes and IFN recep-
tors) were assessed by RT-PCR analysis (Table 3) to obtain
a more detailed picture of the changes in type 1 IFN-
related molecules. The expression of IFN-α s (α1, α2, α4),
the end products of these signaling cascades, has also been
analyzed but expression of IFN-αs was not detected in
either SPF or GF mice (data not shown).
Verification study using microflora-reconstituted (ex-GF) 
mice
To verify whether the observed changes were attributable
to the presence of intestinal flora, we examined gene
expression in microbiota-reconstituted mice. Pregnant GF
mice were cohabited with SPF mice beginning 3 to 5 days
before delivery. The offspring was kept under SPF condi-
tions until the age of 9 weeks and total RNA was prepared
from the large intestine. Real time RT-PCR was performed,
the results of which are shown in Table 4. Significant
changes in gene expression were generally similar to those
presented in Table 3.
Production of type 1 interferon in the small and large 
intestines
To investigate whether IFN-related genes play a significant
role in the immune defense response in the large intes-
tine, we administered an oral interferon inducer,
R11567DA, and used ELISA to determine the amount of
IFN-α produced in the small intestine, large intestine, and
blood. As shown in Figure 1, after 4 hours, high levels of
IFN-α were detected in homogenates of large intestine but
not in small intestine or serum. After 20 hours, IFN-α was
also detected in the small intestine and serum, and at
higher levels than in large intestine. These data suggest
that the large intestine can produce IFN-α very rapidly,
prior to the elevation of blood IFN-α levels, even before
the commencement of IFN-α production in the small
intestine, which contains an abundance of IFN-signaling
molecule mRNAs and would likely encounter the oral IFN
inducers earlier than would the large intestine.
In situ hybridization
To elucidate the cell types responsible for R11567DA-
induced IFN-α production, we performed in situ hybridi-
zation on sections prepared from the small and large
intestines with or without 4-hour R11567DA treatment in
SPF mice (Figure 2 and Figure 3). In situ hybridization
with an IFN-α1-specific probe revealed that IFN-α1 was
expressed in Paneth cells, the small intestine, and discrete
cells distributed in the lamina propria in the large intes-
tine. Similar results have been obtained with probes for
other types of IFN-α-induced genes, such as Ifit1, Irf7 (Fig-
ure 2) and oas1g (data not shown). The localization of
Tlr7 mRNA, which has been shown to be expressed in a
limited number of cell types, including plasmacytoid den-
dritic cells [33,34], showed a similar distribution pattern
to that of the aforementioned IFN-related genes. Both at 4
and 20 hours, the number of IFN-α mRNA positive cells
per mucosal area in the small intestine was larger than
that in the large intestine (Figure 3). However, at 4 hours,
R11567DA treatment increased the number of IFN-α-pos-
itive cells in the large intestine but not in the small intes-
tine (Figure 3), which is in good accordance with the
results of our IFN-α ELISA. The number of Ifit1-positive
cells was increased by R11567DA treatment in both the
small and large intestine, while the increase in the number
of Irf7-positive cells occurred only in the small intestine.
The number of Oas1g and Tlr7 did not change in either
the small or large intestine following R11567DA treat-
ment. At 20 hours, in the small intestines of R1156DA-
treated mice, the number of IFN-α and Irf7-positive cells
increased as compared with the control group, while no
difference was seen in the large intestines. The number ofBMC Genomics 2008, 9:192 http://www.biomedcentral.com/1471-2164/9/192
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Table 3: Verification of the changes in gene expression by quantitative realtime RT-PCR
Gene Name* Gene Symbol qt realtime RT-PCR GeneChip RT-PCR primer/probe ID***
Fold change** p value significant difference GeneChip Probe Set ID
Type 1 interferon-regulatory factors
interferon regulatory factor 1 (IRF1) Irf1 1.00 - - Mm00515191_m1 102401_at
interferon regulatory factor 3 (IRF3) Irf3 1.06 0.479 - Mm00516779_m1 99103_at
interferon regulatory factor 5 (IRF5) Irf5 2.38 0.112 - Mm00496477_m1 93425_at
interferon regulatory factor 6 (IRF6) Irf6 1.50 0.363 - Mm00516797_m1 92440_at
interferon regulatory factor 7 (IRF7) Irf7 2.44 0.031 + Mm00516788_m1 104669_at
interferon dependent positive acting 
transcription factor 3 gamma(IRF9)
Isgf3g 2.53 0.001 - Mm00492679_m1 103634_at
interferon consensus sequence binding protein 1(IRF8) Irf8 1.11 0.299 - Mm00492567_m1 98002_at
Type 1 interferon-inducible genes
interferon-induced protein with 
tetratricopeptide repeats 1
Ifit1 5.22 0.048 + Mm00515153_m1 100981_at
interferon-induced protein with tetratricopeptide 
repeats 2
Ifit2 0.82 0.861 + Mm00492606_m1 103639_at
glucocorticoid-attenuated response gene 49 (GARG-49/
IRG2)
Ifit3 1.99 0.195 - Mm01704846_s1 93956_at
guanylate nucleotide binding protein 2:mGBP-2 Gbp2 2.83 0.091 + Mm00494575_m1 104597_at
expressed sequence AI481100:GTPI Iigp2 2.11 0.060 + Mm00546343_s1 96764_at
chemokine (C-X-C motif) ligand 10:IP-10 Cxcl10 4.69 0.058 - Mm00445235_m1 93858_at
interferon inducible protein 1:LRG-47, Ifi1 Irgm 6.30 0.188 + Mm00492596_m1 97409_at
lectin, galactose binding, soluble 9 Lgals9 1.96 0.023 + Mm00495295_m1 103335_at
interferon gamma induced GTPase Igtp 2.95 0.012 + Mm00497611_m1 160933_at
Type I interferon receptors
interferon (alpha and beta) receptor 1 Ifnar1 0.29 0.424 - Mm00439544_m1 100483_at
interferon (alpha and beta) receptor 2 Ifnar2 1.12 0.599 + Mm00494916_m1 101014_at
Complement-related genes
complement component 1, q subcomponent, alpha 
polypeptide
C1qa 2.24 0.105 + Mm00432142_m1 98562_at
complement component 3 C3 2.74 0.059 + Mm00437858_m1 93497_at
serine (or cysteine) proteinase inhibitor, clade G, 
member 1:complement 1 inhibitor
Serping1 1.41 0.070 + Mm00437834_m1 99081_at
MHC-related genes
Histocompatibility 2, class II antigen A, alpha H2-Aa 1.73 0.197 + Mm01609331_m1 92866_at
MHC class II H2-I-A-beta gene (k haplotype) H2-AB1 1.82 0.022 + H2-AB1-TG04 100998_at
MHC (A.CA/J(H-2K-f) class I antigen H2-Q1 0.88 0.496 + Mm00657093_g1 97125_f_at
MHC class I Q4 beta-2-microglobulin (Qb-1) gene H2-Q4 1.65 0.008 - H2-Q4-TG09 99378_f_at
Q8/9d gene LOC386462 2.22 0.017 + H2-Q78-TG08 98438_f_at
Histocompatibility 2, T region locus 10+17 H2-T10/22/9 1.74 0.114 + H2-T1017-TG11 93865_s_at
Histocompatibility 2, T region locus 23 H2-T23 1.35 0.116 + Mm00439246_g1 98472_at
Other molecules
cytotoxic T lymphocyte-associated protein 2 
alpha
Ctla2a 5.17 0.002 + Mm00484032_g1 96912_s_at
CD52 antigen:CD80? Cd52 2.40 0.029 + Mm00489055_m1 104606_at
* The genes giving a significant (p < 0.05) result in the real-time RT-PCR were shown in bold font.
** Fold change is defined as the ratio of the signal of GF to that of SPF.
*** The primer probe sets were perchased from TaqMan Gene Expression Assays (Applied Biosystems) except for those for H2-AB1, H2-Q4, 
LOC386462, and H2-T10/22/9, which were synthesized by Costum TaqMan gene expression assay (Appried Byosystems) using File Builder 
program (Applied Byosystems). The primer-probe IDs in TaqMan Gene Expression Assays were shown in the table. The sequences of the primer-
probe sets in Custom TaqMan gene expression assay are the following.
H2-AB1-TG04 forward; 5'-CCTGAAGAGCCCCATCACT-3', reverse; 5'-CTTGCTCCGGGCAGACT-3', probe 5'-
ACTGTGCCCTCCACTCCA-3'
H2-Q4-TG09 forward;5'-CCTGGAGCTCGGGAAGGA-3', reverse; 5'-CCGTCAGATCTGTGGTGACATG-3', probe; 5'-
ACAGATCCTCCAAAGGCA-3'
H2-Q78-TG08 forward; 5'-AGGGCCATGAGCAGAGTTTC-3', reverse; 5'-CCCCATGTCACAGCCATACA-3', probe; 5'-
AAGGGCGGCTCTCACA 3'
H2-T1017-TG11 forward; 5'-ACGTGCCATGTGGACCAT-3', reverse 5'-GCAACAATCCAAATCCAAGGCTTTT-3', probe; 5'-
CAGGCTCCCATCTCAG-3'BMC Genomics 2008, 9:192 http://www.biomedcentral.com/1471-2164/9/192
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Tlr7-positive cells decreased in the large intestine at 20
hours.
Immunohistochemistry
To identify the cells responsible for R11567DA-induced
IFN-α production, we performed immunohistochemistry
on sections prepared from the large intestines with or
without 4-hour R11567DA treatment in SPF mice. The
antibody to ISG15, a typical type-1 interferon-stimulated
gene stained discreet single cells or relatively small cell
aggregates in the lamina propria in R11567DA-treated
colons (Figure 4A). No signal was detected in the epithe-
lial layers. Multiple staining by combinations of antibod-
ies including dendritic cell markers revealed that in the
large intestine ISG15 was produced in a small proportion
of CD11b+ cells (Figure 4B, C, E) and mPDCA1+ cells (Fig-
ure 4E) although more than half of the ISG15+ cells were
not stained by either CD11b or mPDCA1 antibody. Virtu-
ally no ISG15+ cells were found among the CD11c+ cells
(Figure 4D).
Discussion
In the present study, transcriptome analysis was per-
formed on colon tissue. This approach to profile tran-
scription in whole tissues may be limited in that the
detected changes are derived from composite changes in
plural cell types. However, previous transcriptome studies
that have focused on intestinal epithelial cells (IECs)
[20,28] did not appear to adequately characterize the
microflora-induced immunological changes in terms of
transcriptional profiling, even in the small IECs, the phys-
iology of which is supposed to be profoundly affected by
a variety of GALT-derived cells and/or mediators.
Although recent studies have revealed a wide array of
immune-oriented functions of IECs [35,36], the spectrum
of immune functions carried out by IECs is limited. By
analyses of gene expression using whole colons from
commensal GF mice, certain bacteria have been reported
to increase the expression of IFN-γ-related genes and
immunoglobulins [14,15,21].
In the present study, the expression of CRSs was increased
by commensal bacteria. CRSs are cationic peptides that
have a pro-region with high similarity to the pro-region of
α-defensins. Although mature CRS peptides have no
sequence homology or structural homology to any other
known anti-microbial peptides, CRSs have been reported
to co-localize with cryptdins in the granules of Paneth
cells in similar amounts to cryptdins and to have potent
microbial bacteriacidal activity [37-39]. A previous study
using the differential display technique showed higher
expression of CRS4C in the small intestines of SPF ICR
mice than of GF ICR mice [40]. If CRSs function as the
first-line defense against microbial invasion, like other
various intestinal anti-microbial peptides, it is reasonable
that the expression of CRSs in the small and large intes-
tines of SPF mice is higher than that of GF mice. However,
apparently normal colons do not have Paneth cells, which
are the main sites of cryptdin and CRS localization in the
small intestine. Although metaplastic Paneth cells
expressing antimicrobial proteins such as cryptdins and
lysozymes are known to appear in inflammed colons
[41,42], histological examination detected no such cells
in the large intestines of SPF mice (data not shown).
Because cryptdins have been reported to also be present in
the epithelial cells of the small intestines [40], CRSs may
be expressed in the colonic epithelium. The localization
and biological implication of CRSs remains to be eluci-
dated in future research.
The most interesting finding of the present study is the
possible importance of IFN-α in the defense systems of
the large intestine. The most prominent difference in the
expression of professional immune molecules was
observed for genes involved in the IFN-α induction path-
way. Many of them, such as Ifit1, 2 [43], Ifi47 [44], Tgtp
[45], Gbp2 and 4 [46], Irgm [47]. Lgals9 [48], and Rsad2
[49] were originally identified as IFN-α-inducible genes.
One molecule, Irf7, is a rate limiting transcription factor
located in the center of a self-amplifying positive feedback
loop of massive IFN-α production [50]. Microbial infec-
tion induces phosphorylation of IRF7 protein, and phoso-
phorylated IRF7 is transported into nuclei to strongly
induce the expression of IFN-αs and Irf7 itself. In the pres-
ence of kinase activated by infectious agents, newly syn-
thesized IRF7 continues to activate the loop resulting in
the explosive production of IFN-αs. The inducibility of
IFN-α production in various tissues/cells and their steady
state level of IRF7 proteins are known to be closely corre-
lated [51]. Isgf3g (Irf9) and Stat1 are 2 components of
ISGF3, a signaling complex that transduces the signal
from receptors of IFN-α/β and induces the expression of
IFN-α-related molecules including double-stranded RNA-
dependent kinase Eif2ak2 (Prkr) [52], 2'-5' oligozdenylate
synthetase 1A (Oas1a or Oas1g) [53], ISG15 ubiquitin-
like modifier (G1p2 or Isg15) [54], and especially, Stat1
and Irf7 [55]. Changes in the expression of Stat2, the other
component of ISGF3, have also been observed. In con-
trast, the expression of other interferon regulatory factors
such as Irf1, Irf2, and Irf8 did not show differences, and
expression of end-products such as the IFN-αs, a2 and a4
was not detected. These data suggest that, although GF
and SPF mice usually do not express IFN-α, or do so at
extremely low levels, once the stimulatory signals are trig-
gered, they might produce different levels of IFN-α due to
the difference in basal expression levels of rate-limiting
regulatory factors of IFN-α production.
It is unknown, among the wide array of signaling mole-
cules involved in IFN-α production, why only the rela-BMC Genomics 2008, 9:192 http://www.biomedcentral.com/1471-2164/9/192
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tively confined members showed differences in the
present study. One possible explanation was provided by
the results of IFN-α induction experiments. Administra-
tion of oral IFN-α inducers resulted in elevated tissue IFN-
α content in both the small and large intestines. However,
in spite of the high basal levels of IFN-α-related genes,
including Irf7, the production of IFN-α in the small intes-
tine occurred later than in the large intestines. The
extreme rapidness of IFN production in the large intestine
suggests a possible involvement of Type 1 interferon pro-
ducing cells (IPCs), which are virtually identical to plas-
macytoid dendritic cells (pDCs) [56]. IPCs express
extremely high levels of Irf7 mRNA and protein constitu-
tively, and can produce 100 to 1000 times more IFN than
Table 4: Changes in gene expression of flora-reconstituted mice (quantitative realtime RT-PCR)
Gene Name* Gene Symbol qt realtime RT-PCR RT-PCR
Fold change** p value primer/probe ID***
Type 1 interferon-reguratory factors
interferon regulatory factor 1 (IRF1) Irf1 1.00 - Mm00515191_m1
interferon regulatory factor 3 (IRF3) Irf3 1.84 0.003 Mm00516779_m1
interferon regulatory factor 5 (IRF5) Irf5 3.05 0.053 Mm00496477_m1
interferon regulatory factor 6 (IRF6) Irf6 6.47 0.055 Mm00516797_m1
interferon regulatory factor 7 (IRF7) Irf7 4.42 <0.001 Mm00516788_m1
interferon dependent positive acting transcription factor 3 
gamma(IRF9)
Isgf3g 2.87 0.033 Mm00492679_m1
interferon consensus sequence binding protein 1(IRF8) Irf8 1.89 0.043 Mm00492567_m1
Type 1 interferon-inducible genes
interferon-induced protein with tetratricopeptide repeats 1 Ifit1 4.13 0.029 Mm00515153_m1
interferon-induced protein with tetratricopeptide repeats 2 Ifit2 5.18 0.233 Mm00492606_m1
glucocorticoid-attenuated response gene 49 (GARG-49/IRG2) Ifit3 12.77 0.095 Mm01704846_s1
guanylate nucleotide binding protein 2:mGBP-2 Gbp2 3.66 0.069 Mm00494575_m1
expressed sequence AI481100:GTPI Iigp2 4.43 0.008 Mm00546343_s1
chemokine (C-X-C motif) ligand 10:IP-10 Cxcl10 14.33 0.133 Mm00445235_m1
interferon inducible protein 1:LRG-47, Ifi1 Irgm 7.14 0.177 Mm00492596_m1
lectin, galactose binding, soluble 9 Lgals9 4.03 0.008 Mm00495295_m1
interferon gamma induced GTPase Igtp 3.22 0.132 Mm00497611_m1
IFN- type I-induced and dsRNA-activated kinase Eif2ak2 2.07 0.040 Mm00440966_m1
2'-5' oligoadenylate synthetase 1A Oas1a 3.18 0.046 Mm00836412_m1
2'-5' oligoadenylate synthetase 1B Oas1b 13.05 0.052 Mm00449297_m1
TAP binding protein Tapbp 1.86 0.046 Mm00493417_m1
Type I interferon receptors
interferon (alpha and beta) receptor 1 Ifnar1 1.84 0.017 Mm00439544_m1
interferon (alpha and beta) receptor 2 Ifnar2 2.06 0.010 Mm00494916_m1
Complement-related genes
complement component 1, q subcomponent, alpha polypeptide C1qa 1.87 0.178 Mm00432142_m1
complement component 3 C3 2.08 0.141 Mm00437858_m1
serine (or cysteine) proteinase inhibitor, clade G, member 1: 
complement 1 inhibitor
Serping1 2.18 0.005 Mm00437834_m1
MHC-related genes
Histocompatibility 2, class II antigen A, alpha H2-Aa 2.72 0.266 Mm01609331_m1
MHC class II H2-I-A-beta gene (k haplotype) H2-AB1 3.42 0.041 H2-AB1-TG04
MHC (A.CA/J(H-2K-f) class I antigen H2-Q1 3.47 0.356 Mm00657093_g1
MHC class I Q4 beta-2-microglobulin (Qb-1) gene H2-Q4 3.83 0.032 H2-Q4-TG09
Q8/9d gene LOC386462 11.69 0.153 H2-Q78-TG08
Histocompatibility 2, T region locus 10+17 H2-T10/22/9 8.06 0.006 H2-T1017-TG11
Histocompatibility 2, T region locus 23 H2-T23 1.10 0.762 Mm00439246_g1
Other molecules
cytotoxic T lymphocyte-associated protein 2 alpha Ctla2a 9.48 0.139 Mm00484032_g1
CD52 antigen Cd52 3.05 0.095 Mm00489055_m1
signal transducer and activator of transcription 1 Stat1 4.66 0.026 Mm00439518_m1
signal transducer and activator of transcription 2 Stat2 3.81 0.015 Mm00490880_m1
* The genes giving a significant (p < 0.05) result in the real-time RT-PCR were shown in bold font.
** Fold change is defined as the ratio of the signal of GF to that of SPF.
*** See the legend of Table 3.BMC Genomics 2008, 9:192 http://www.biomedcentral.com/1471-2164/9/192
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other blood cell types within several hours following
stimulation.
This assumption was further supported by our in situ
hybridization analysis using specific probes against the
IFN-α-inducible genes, Ifnal, Ifit, Irf7, and Oas1g, and the
plasmacytoid dendritic cell marker Tlr7. In the small
intestine, histological analysis clearly indicated that the
cells which had positive signals for type 1 IFN-related
genes and Tlr7 were mainly Paneth cells. In the large intes-
tine, all signals were located in the mononuclear cells scat-
tered predominantly in the lamina propria, although
further examination is necessary to determine whether
these signals were generated from the same cells. In
accordance with the results of our IFN-α ELISA, the
number of Ifna1-positive cells increased in the large intes-
tine but not in the small intestine at 4 hours. The increase
in Irf7-positive cells in the small intestine may reflect
amplification of the IRF7 pool, which is a prerequisite for
massive IFN production in most cells types except for
IPCs. In good agreement with the results of IFN-α ELISA
at 20 hours, the numbers of IFN-α- and Irf7-positive cells
increased in the small intestine. The increase in the
number of these cells in the large intestine ceased at this
time point, suggesting that the detected immunoreactive
IFN-α might represent circulating IFN-α in the blood.
These data, collectively, address the possibility that IFN
production and biological defense by IFN in the large
intestine is borne mainly by IPCs, presumably recruited
from the bloodstream to the intestinal lamina propria.
Finally, we performed immunohistochemical analysis to
confirm whether the cells responsible for IFN-α produc-
tion in the present study are IPCs/pDCs. We have screened
several antibodies raised against type 1 IFN-related genes
and found that the antibody for ISG15, a well-known IFN-
stimulated gene [55,57], stained the cells in the lamina
propria of the colon at 4 hours after IFN-α inducer treat-
ment. Multiple staining by a combination of anti-ISG15
antibody and various CD markers has demonstrated that
ISG15+ cells contains CD11b+ cells and mPDCA1+ cells
but not CD11c+ cells. Conventionally, pDCs (or IPCs)
have been identified as CD11c+B220+Gr-1+  cells or
mPDCA1+ cells. However, recent studies suggested the
phenotype of pDCs, especially in the peripheral tissues,
may have a wide variation [58,59]. Takenaka S. et al [33]
reported that, in the colons of BALB/c and C57BL/6 mice,
many mPDCA1+ cells exist but they are neither CD11c+
nor CD11b+, and no typical CD11c+B220+Gr-1+ pDCs
were present. These findings have also been obtained in
the colons of IQI mice in our study (data not shown): 1)
CD11b+ cells were predominant in the colonic lamina
propria; 2) the majority of mPDCA1+ cells was stained by
neither anti-CD11b nor anti-CD11c antibodies; 3) typical
pDCs (i.e., CD11c+B220+Gr-1+  cells) were virtually
absent. We have found that some CD11b+  cells and
mPDCA1+ cells were co-stained with anti-ISG15 antibody,
but more than half of ISG15+ cells were double-negative
for CD11b and mPDCA1. Colonic IPC may therefore be
comprised of multiple cell populations with unique phe-
notypic characteristics distinct from conventional pDCs/
IPCs. Accordingly, IFN-α production in IBD model mice
has been noted in both CD11b+ and CD11c+ dendritic
cells in colonic lamina propria [60]. However, the sensi-
tivity and specificity of immunohistochemistry are lim-
ited and further extensive studies are necessary to clarify
the functional and phenotypic characteristics of colonic
IPCs.
The content of IFN-αs after R11567DA administration Figure 1
The content of IFN-αs after R11567DA administration. Four hours after oral administration of R11567DA at 100 mg/
kg, the small and large intestines were removed, homogenized, and centrifuged. The amounts of IFN-αs were measured by 
ELISA as described in Materials and Methods. Data represent mean ± SEM (n = 3). LI, large intestine; SI, small intestine, N.D., 
not detected (under detection limit), *, p < 0.0001 vs SI. Without R11567DA treatment, IFN-αs were not detected in any tis-
sues or sera. This experiment was repeated twice with similar results.BMC Genomics 2008, 9:192 http://www.biomedcentral.com/1471-2164/9/192
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Among the immune-related genes whose expression dif-
fered in the presence and absence of intestinal flora in the
present GeneChip analysis, the IFN-related genes, MHC-
related genes, some complements, and immunoglobulins
were expressed at lower levels in SPF mice than in GF
mice. This seems somewhat paradoxical because it is plau-
sible that contact with high levels of microorganisms in
SPF mice may result in enhancement of certain immuno-
logical defense systems in the large intestine. Along this
line, Chowdhury et al. [61] reported that the expression of
IFN-related genes including Irf7, Stat1, Stat2 and Tap1 in
the small intestines was increased by the colonization of
GF piglets with adult conventional swine feces. The dis-
crepancy between our data and theirs may be explainable
by the differences in various experimental settings such as
the host animal (mouse vs. swine), RNA source (large
intestine tissue vs. small intestinal epithelial cell), micro-
bial status (SPF vs. conventional), and age of animals (9
vs. 2 weeks old). However, we think that the difference in
the period after colonization may be responsible for the
difference in expression of IFN-related genes between our
study and theirs. The inflammation induced by microbial
colonization of GF animals has been known to be only
temporary and cease within several weeks [62,63]. After
the inflammation is terminated, histological findings
return to a state apparently indistinguishable from the
normal intestines of mice genuinely harboring the
microbes. Therefore, the up-regulation of IFN-related
genes in the midst of or shortly after inflammation, and
their down-regulation after a long period of resumption
of integrity of tissues and adaptation to enteric microbes
may be quite compatible and it appears that the IFN sys-
In situ hybridization for mRNAs of IFN-α-related genes and Tlr7 in the small and large intestines Figure 2
In situ hybridization for mRNAs of IFN-α-related genes and Tlr7 in the small and large intestines. A. Photomi-
crographs showing localization of Ifna1, Ifit1, Irf7 and Tlr7. In the small intestine, all signals for Ifna1, Ifit1, Irf7 and Tlr7 were 
detected in Paneth cells. In the large intestines, the signals were detected in the discrete cells distributed in lamina propria, 
though further examination is necessary to elucidate whether these signals were generated from the same cells, and to deter-
mine their cellular identity. Five sections per tissue were prepared from each of 8 mice. Representative photographs were 
shown.BMC Genomics 2008, 9:192 http://www.biomedcentral.com/1471-2164/9/192
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tem may play an extraordinary role in the immunological
confrontation, negotiation and reconciliation between
microbiota and host animals. The immune systems of the
gastrointestinal tract are known to have potent anti-
inflammatory and regulatory properties. In the intestinal
immune systems, constant exposure to bacteria-derived
immunostimulating molecules may crowd up the thresh-
old of activation of the inflammatory aspect of the
immune system. Alternatively, the immune system may
be programmed to develop anti-inflammatory and/or reg-
ulatory responses to microbial stimuli as a default setting,
unless certain specialized machinery such as toll-like
receptors provide the additional signature indicating the
stimuli are derived from specific dangerous pathogens.
The down-regulation of immune-related genes may repre-
sent certain acquired characteristics of the intestinal
immune systems to adapt to circumstances in which
immune cells are continually exposed to vast amounts of
commensal bacteria.
Conclusion
The present study suggests that microbial colonization,
while inducing the expression of certain anti-microbial
peptides, results in the down-regulation of a relatively
limited range of genes responsible for host defense
responses in the LI. This may reflect the adaptation proc-
ess of immune systems in the LI to prevent excessive
inflammation with respect to continuous microbial expo-
sure. In particular, an extraordinary role of type I IFN has
been suggested. Further, the repertoire of anti-microbial
peptides and the extraordinary role of type 1 IFN-produc-
Quantitation of the numbers of cells positive for Ifna1, Irf7, Ifit1, Oas1g, or Tlr7 Figure 3
Quantitation of the numbers of cells positive for Ifna1, Irf7, Ifit1, Oas1g, or Tlr7. Open and closed columns repre-
sent data obtained from saline- and R11567DA- treated mice, respectively. Sections prepared from 8 mice per group were 
used. Five low-power photographs were taken for each section, and the number of positive cells was counted and normalized 
to per 0.8 mm2 of intestinal mucosa. Data represent mean ± SEM. *P < 0.05, **P < 0.01, significantly different from the 
R11567DA (-) group.BMC Genomics 2008, 9:192 http://www.biomedcentral.com/1471-2164/9/192
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Immunofluorescence detection of IFN-α producing cells Figure 4
Immunofluorescence detection of IFN-α producing cells. Cryostat sections of colonic tissues from mice 4 hr after the 
administration of saline or R11567DA. Sections were multi-labeled with anti-ISG and anti-CD11b, anti-CD11c, anti-mPDCA1 
or DAPI. A, ISG15 signals were observed in colonic lamina propria of R11567DA-treated mice while saline treatment pro-
duced no signal. B, C. Portions of ISG15+ cells (green) were co-stained (yellow) with anti-CD11b antibody (red). Nuclei were 
visualized by DAPI staining (blue) in Panel B. D, ISG15+CD11c+ double positive cells (yellow) were scarcely found. E, In addition 
to ISG15+CD11b+ double-positive cells (yellow), ISG15+mPDCA1+ double positive cells (white) were found. However, more 
than half of ISG15+ cells was stained by neither anti-CD11b nor anti-mPDCA1 antibodies (data not shown).BMC Genomics 2008, 9:192 http://www.biomedcentral.com/1471-2164/9/192
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ing cells in the LI have been found to be distinct from
those in the SI.
Methods
Animals
Male germ-free (GF) and specific pathogen-free (SPF) IQI/
Jic mice were bred and maintained in the laboratory of the
Central Institute for Experimental Animals (CIEA, Kawa-
saki, Kanagwa, Japan). GF mice were housed in a Trexler-
type flexible film isolator in a standard germ-free state and
screened on a weekly basis for germ-free status by sam-
pling feces sterilely and culturing on MRS-agar plates
under aerobic and anaerobic conditions. All GF-, SPF-,
and ex-GF mice were kept on a 12:12-h light/dark cycle at
a temperature of 22 ± 2°C. Microflora reconstitution was
performed by transferring the pregnant females to an SPF
facility, where they were reared in the presence of male
SPF mice beginning at 3 to 5 days before the expected
natal day, and the newborn male mice were used as
microflora-reconstituted ex-GF mice. All animal proce-
dures were approved by the institution's ethical commit-
tee for care and use of laboratory animals in research.
Tissue dissection
Nine-week old mice were sacrificed by cervical dislocation
and the colon was dissected (the colon was not divided
into proximal and distal sections and was treated as a sin-
gle intestinal section). Tissues destined for in situ hybrid-
ization were rinsed in phosphate-buffered saline (PBS),
cut longitudinally, fixed in formalin or paraformalde-
hyde, and embedded in paraffin. Tissues destined for
immunohistochemistry were embedded in OCT com-
pound (Tissue-Tek, Sakura Finetechnical. Tokyo, Japan)
and frozen in liquid nitrogen. Tissues destined for RNA
extraction were flash-frozen in liquid nitrogen after wash-
ing with ice-cold PBS.
Microarray analysis
Total RNA was extracted from mice (n = 3 per each group)
using TRIzol (Life Technologies, Rockville, TX) and re-
purified by RNeasy spin columns (Qiagen, Valencia, CA),
according to the manufacturer's instructions. All samples
were monitored using an Agilent Bioanalyzer (Agilent
Biotechnologies, Boeblingen, Germany) and consistently
demonstrated high-quality RNA (28S/18S ratio, ~2). The
labeled cRNA prepared by in vitro transcription (Enzo
Biochem, New York, NY) was fragmented, hybridized to
an MG-U74Av2 array (Affymetrix, Santa Clara, CA) using
an Affymetrix fluidics station, and scanned with an
Affymetrix scanner, according to the Affymetrix protocols.
Data were analyzed using the Affymetrix Microarray Suite
(MAS) v.5.0 with all of the parameters set at default values
(a global normalization was applied). The probe sets that
had 2 or 3 absent A MAS detection calls per group (3 sam-
ples) in all groups were excluded; therefore, genes that
had more than 2 present calls in any one of the groups
were included in the analysis). Further, probe sets with
signal intensities less than 50 were omitted because pre-
liminary evaluation by RT-PCR revealed poor reproduci-
bility for genes with lower signal intensities. Statistical
analyses were performed by Welch's t-test. Affymetrix
MAS5.0-normalized signal intensities were submitted to
the Gene Expression Omnibus [64] and are available
under the series ID: GSE8006.
Real-time RT-PCR
All mouse primer and probe sets used TaqMan® Gene
Expression Assays (Applied Biosystems, Foster City, CA)
or Custom TaqMan® Gene Expression Assays (Applied
Biosystems). Total RNA was purified from large intestine
(n = 4–6 per group) as described in the previous para-
graph. Reverse transcription was performed with 1 ug of
total RNA using TaqMan Reverse Transcription Reagents
(Applied Biosystems). Real time-PCR analysis was per-
formed using an ABI Prism 7900HT (Applied Biosystems)
with the following thermal cycling conditions: 1 cycle at
55°C for 10 min, followed by 40 cycles at 95°C for 15 sec
and 60°C for 1 min. All samples were run in triplicates.
Data were normalized by using Irf1, the expression of
which had been found to be quite stable among groups in
the present experimental setting, as determined by Gene-
Chip and RT-PCR analyses. GADPH and beta-actin fluctu-
ated greatly and slightly, respectively, which is
presumably a reflection of the massive changes in tissue
organization among microflora -absent and microflora -
present intestines.
Cloning and sequencing of CRSs
Fragments of the Defcrs family were amplified using the
primers common for the family (forward, 5'-ATGAAGA-
GACTTGTCCTCCTC-3'; reverse, 5'-CTTCTTGAAGAGCA-
GAGCCTT-3') from total RNA from the large intestine of
GF- and SPF mice by RT-PCR using TaqMan Reverse Tran-
scription Reagents (Applied Biosystems) and Advantage
HF2 PCR kit (Clonhech, Mountain View, CA). The frag-
ments were cloned into pT7Blue vector using a pT7Tblue
Perfectly Blunt Cloning Kit (Merck, Darmstadt, Germany)
according to the manufacture's instructions. The inserts
were checked by colony-direct PCR and sequenced using
ABI PRISM® 3100 Genetic Analyzer (Applied Biosystems).
The dendrogram was made from the sequence data by
Contig Express and the Align X equipped in the Vector NTI
advance Ver.9 (Invitrogen, Carlsbad, CA). BLAST searches
on the NCBI database were performed to identify the gene
name.
Induction and quantitation of IFN-α protein
Tilorone analog R11567DA (Sigma, St.Louis, MO) was
administered p.o. to IQI SPF mice at a dose of 100 mg/kg
[65]. At 4 and 20 hours later, after cervical dislocation,BMC Genomics 2008, 9:192 http://www.biomedcentral.com/1471-2164/9/192
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blood samples were collected from the cardiac ventricle.
The small and large intestines were then dissected and
snap-frozen in liquid nitrogen. The blood was allowed to
clot at room temperature for more than 30 minutes and
centrifuged to obtain serum samples. The sera and intes-
tines were stored at -80°C until use. At assay, the intestinal
samples were thawed, homogenized in PBS buffer with
protease inhibitor cocktail Mini (Roche Diagnotics, Basel,
Switzerland), and centrifuged at 15000 g for 5 min at 4°C,
and the supernatant was saved. The amount of IFN-α pro-
tein in the supernatant and serum was assessed using a
commercially available IFN-α ELISA kit (PBL Biomedical
Laboratories, Piscataway, NJ), which specifically detects
the IFN-αs, α4, α5,α6 and α9.
In situ hybridization
The protocol for in situ hybridization has been described
previously [66]. Briefly, after acetylation, dehydration,
and delipidation pretreatment, mRNAs in sections were
hybridized with specific Brigati-Tail oligonucleotide
probes using a MicroProbe Staining system (Falma, Tokyo
Japan). The sequences of the probes used were Ifna1, 5'-
TTCAGGGGAAATTCCTGCACCCCCA-3'; Ifit1, 5'-TTCG-
CAAAGCAGGCCATGGC-3'; Irf7, 5'-ATTTTCCGTGGCT-
GGGCCCACA-3'; Tlr7, 5'-
TTTCCATGGTCCTGCTGGCCGA-3'; Oaslg, 5'-TTGGTT-
GGGCGCTGCTTCAGGA-3'. After post hybridization, the
biotin-labeled hybrids were sequentially detected with
alkaline phosphatase-conjugated streptavidin with stable
DAB. Hybridization with antisense oligonucleotide
probes for respective mRNAs gave no specific signals (data
not shown).
Immunohistochemistry
Immunohistochemistry was performed on frozen-sec-
tions of mid-colon post-fixed by acetone using the follow-
ing primary antibodies, PE- or FITC-conjugated anti-
CD11c (rat mAb, M1/70, BD Pharmingen, Franklin Lakes,
NJ), PE- or FITC-anti-CD11b (hamster mAb, HL3, BD
Pharmingen), PE- or FITC- or APC-anti-mPDCA1 (rat
mAb, JF05-1C2.4.1, Miltenyi Biotec, Bergisch Gladbach,
Germany), anti-ISG15 (rabbit pAb, AP1150a, Abgent,
SanDiego, CA). Sections were incubated overnight at 4°C
in primary antibodies diluted in antibody diluent (DAKO,
Glostrup (Denmark), Secondary antibodies (Alexafluor-
488-, or Alexafluor-647-labeled anti-rabbit IgGs) and
DAPI (Molecular Probe), diluted in antibody diluent,
were reacted for 2 h at room temperature. Sections were
viewed by a laser-scanning confocal microscope FV1000
(Olimpus, Tokyo, Japan). In control sections, primary
antibodies were omitted and no staining was observed in
these sections.
List of abbreviations
CRS: cryptdin-related sequences; CV: conventional; ex-GF:
miroflora-reconstituted mice; GF: germ-free; IECs: intesti-
nal epithelial cells, IFN: interferon; IPC: type 1 interferon
producing cells; LI: large intestine; PP: Peyer's patches;
SPF: specific pathogen-free.
Authors' contributions
KM participated in most experiments. MY participated in
the design of the study, immunohistochemistry, data
analysis and coordination, and drafted the manuscript.
NA carried out the anterior half of the experiments of this
study. MN and KT participated in RT-PCR. SaI and SeI car-
ried out in situ hybridization. KH and YO participated in
the design and coordination of the microflora reconstitu-
tion experiments. AI participated in the design of the
study and coordination. KW conceived the study and par-
ticipated in its design and coordination. All authors read
and approved the final manuscript.
References
1. Backhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI: Host-
bacterial mutualism in the human intestine.  Science 2005,
307(5717):1915-1920.
2. Kelly D, Conway S, Aminov R: Commensal gut bacteria: mech-
anisms of immune modulation.  Trends Immunol 2005,
26(6):326-333.
3. Macpherson AJ, Geuking MB, McCoy KD: Immune responses that
adapt the intestinal mucosa to commensal intestinal bacte-
ria.  Immunology 2005, 115(2):153-162.
4. Forchielli ML, Walker WA: The role of gut-associated lymphoid
tissues and mucosal defence.  Br J Nutr 2005, 93 Suppl 1:S41-8.
5. Macpherson AJ, Harris NL: Interactions between commensal
intestinal bacteria and the immune system.  Nat Rev Immunol
2004, 4(6):478-485.
6. Little MC, Bell LV, Cliffe LJ, Else KJ: The characterization of
intraepithelial lymphocytes, lamina propria leukocytes, and
isolated lymphoid follicles in the large intestine of mice
infected with the intestinal nematode parasite Trichuris
muris.  J Immunol 2005, 175(10):6713-6722.
7. Resendiz-Albor AA, Esquivel R, Lopez-Revilla R, Verdin L, Moreno-
Fierros L: Striking phenotypic and functional differences in
lamina propria lymphocytes from the large and small intes-
tine of mice.  Life Sci 2005, 76(24):2783-2803.
8. Maeda Y, Noda S, Tanaka K, Sawamura S, Aiba Y, Ishikawa H, Haseg-
awa H, Kawabe N, Miyasaka M, Koga Y: The failure of oral toler-
ance induction is functionally coupled to the absence of T
cells in Peyer's patches under germfree conditions.  Immunob-
iology 2001, 204(4):442-457.
9. Yamanaka T, Helgeland L, Farstad IN, Fukushima H, Midtvedt T,
Brandtzaeg P: Microbial colonization drives lymphocyte accu-
mulation and differentiation in the follicle-associated epithe-
lium of Peyer's patches.  J Immunol 2003, 170(2):816-822.
10. Ayabe T, Satchell DP, Pesendorfer P, Tanabe H, Wilson CL, Hagen SJ,
Ouellette AJ: Activation of Paneth cell alpha-defensins in
mouse small intestine.  J Biol Chem 2002, 277(7):5219-28. Epub
2001 Dec 3..
11. Bry L, Falk P, Huttner K, Ouellette A, Midtvedt T, Gordon JI: Paneth
cell differentiation in the developing intestine of normal and
transgenic mice.  Proc Natl Acad Sci U S A 1994,
91(22):10335-10339.
12. Satoh Y, Ishikawa K, Ono K, Vollrath L: Quantitative light micro-
scopic observations on Paneth cells of germ-free and ex-
germ-free Wistar rats.  Digestion 1986, 34(2):115-121.
13. Mysorekar IU, Lorenz RG, Gordon JI: A gnotobiotic transgenic
mouse model for studying interactions between small intes-
tinal enterocytes and intraepithelial lymphocytes.  J Biol Chem
2002, 277(40):37811-9. Epub 2002 Jul 22..BMC Genomics 2008, 9:192 http://www.biomedcentral.com/1471-2164/9/192
Page 14 of 15
(page number not for citation purposes)
14. Keilbaugh SA, Shin ME, Banchereau RF, McVay LD, Boyko N, Artis D,
Cebra JJ, Wu GD: Activation of RegIIIbeta/gamma and inter-
feron gamma expression in the intestinal tract of SCID mice:
an innate response to bacterial colonisation of the gut.  Gut
2005, 54(5):623-629.
15. Rhee SJ, Walker WA, Cherayil BJ: Developmentally regulated
intestinal expression of IFN-gamma and its target genes and
the age-specific response to enteric Salmonella infection.  J
Immunol 2005, 175(2):1127-1136.
16. Tanaka K, Ishikawa H: Role of intestinal bacterial flora in oral
tolerance induction.  Histol Histopathol 2004, 19(3):907-914.
17. Matsumoto S, Nanno M, Watanabe N, Miyashita M, Amasaki H,
Suzuki K, Umesaki Y: Physiological roles of gammadelta T-cell
receptor intraepithelial lymphocytes in cytoproliferation
and differentiation of mouse intestinal epithelial cells.  Immu-
nology 1999, 97(1):18-25.
18. Rask C, Evertsson S, Telemo E, Wold AE: A full flora, but not
monocolonization by Escherichia coli or lactobacilli, sup-
ports tolerogenic processing of a fed antigen.  Scand J Immunol
2005, 61(6):529-535.
19. Prioult G, Fliss I, Pecquet S: Effect of probiotic bacteria on induc-
tion and maintenance of oral tolerance to beta-lactoglobulin
in gnotobiotic mice.  Clin Diagn Lab Immunol 2003, 10(5):787-792.
20. Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, Gordon JI:
Molecular analysis of commensal host-microbial relation-
ships in the intestine.  Science 2001, 291(5505):881-884.
21. Mutch DM, Simmering R, Donnicola D, Fotopoulos G, Holzwarth JA,
Williamson G, Corthesy-Theulaz I: Impact of commensal micro-
biota on murine gastrointestinal tract gene ontologies.  Phys-
iol Genomics 2004, 19(1):22-31. Epub 2004 Jun 29..
22. Kato H: Animal models derived from the ICR mouse for
human diseases.  Medical Immunology 1989, 17:353-61 (in Japa-
nese).
23. Saegusa J, Kiuchi Y, Itoh T: Antinucleolar autoantibody induced
in mice by mercuric chloride--strain difference in susceptibil-
ity.  Jikken Dobutsu 1990, 39(4):597-599.
24. Saegusa J, Yasuda A, Kubota H: IQI/Jic mice have thymic B cells.
Exp Anim 1996, 45(4):353-360.
25. Saegusa J, Kubota H: Sialadenitis in IQI/Jic mice: a new animal
model of Sjogren's syndrome.  J Vet Med Sci 1997,
59(10):897-903.
26. Ikeda M, Kuroki K, Suzuki H, Nakayama H, Saegusa J, Doi K: Picryl
chloride-induced allergic dermatitis in IQI/Jic female mice.
Exp Toxicol Pathol 2000, 52(3):235-240.
27. Jung JY, Saegusa J, Nakayama H, Doi K: Comparative study on pic-
ryl chloride (PCL)-induced contact dermatitis in female IQI/
Jic and BALB/c mice.  Exp Anim 2004, 53(2):89-96.
28. Fukushima K, Ogawa H, Takahashi K, Naito H, Funayama Y, Kitayama
T, Yonezawa H, Sasaki I: Non-pathogenic bacteria modulate
colonic epithelial gene expression in germ-free mice.  Scand J
Gastroenterol 2003, 38(6):626-634.
29. Hughes AL, Nei M: Evolution of the major histocompatibility
complex: independent origin of nonclassical class I genes in
different groups of mammals.  Mol Biol Evol 1989, 6(6):559-579.
30. Wu M, van Kaer L, Itohara S, Tonegawa S: Highly restricted
expression of the thymus leukemia antigens on intestinal
epithelial cells.  J Exp Med 1991, 174(1):213-218.
31. Israel A, Kimura A, Fournier A, Fellous M, Kourilsky P: Interferon
response sequence potentiates activity of an enhancer in the
promoter region of a mouse H-2 gene.  Nature 1986,
322(6081):743-746.
32. Raval A, Puri N, Rath PC, Saxena RK: Cytokine regulation of
expression of class I MHC antigens.  Exp Mol Med 1998,
30(1):1-13.
33. Doxsee CL, Riter TR, Reiter MJ, Gibson SJ, Vasilakos JP, Kedl RM:
The immune response modifier and Toll-like receptor 7 ago-
nist S-27609 selectively induces IL-12 and TNF-alpha produc-
tion in CD11c+CD11b+CD8- dendritic cells.  J Immunol 2003,
171(3):1156-1163.
34. Edwards AD, Diebold SS, Slack EM, Tomizawa H, Hemmi H, Kaisho
T, Akira S, Reis e Sousa C: Toll-like receptor expression in
murine DC subsets: lack of TLR7 expression by CD8 alpha+
DC correlates with unresponsiveness to imidazoquinolines.
Eur J Immunol 2003, 33(4):827-833.
35. Shao L, Kamalu O, Mayer L: Non-classical MHC class I molecules
on intestinal epithelial cells: mediators of mucosal crosstalk.
Immunol Rev 2005, 206:160-176.
36. Snoeck V, Goddeeris B, Cox E: The role of enterocytes in the
intestinal barrier function and antigen uptake.  Microbes Infect
2005, 7(7-8):997-1004.
37. Hornef MW, Putsep K, Karlsson J, Refai E, Andersson M: Increased
diversity of intestinal antimicrobial peptides by covalent
dimer formation.  Nat Immunol 2004, 5(8):836-43. Epub 2004 Jul
4..
38. Huttner KM, Ouellette AJ: A family of defensin-like genes codes
for diverse cysteine-rich peptides in mouse Paneth cells.
Genomics 1994, 24(1):99-109.
39. Putsep K, Axelsson LG, Boman A, Midtvedt T, Normark S, Boman
HG, Andersson M: Germ-free and colonized mice generate the
same products from enteric prodefensins.  J Biol Chem 2000,
275(51):40478-40482.
40. Ogawa H, Fukushima K, Sasaki I, Matsuno S: Identification of genes
involved in mucosal defense and inflammation associated
with normal enteric bacteria.  Am J Physiol Gastrointest Liver Physiol
2000, 279(3):G492-9.
41. Cunliffe RN: Alpha-defensins in the gastrointestinal tract.  Mol
Immunol 2003, 40(7):463-467.
42. Wada R, Yamaguchi T, Tadokoro K: Colonic Paneth cell metapla-
sia is pre-neoplastic condition of colonic cancer or not?  J Car-
cinog 2005, 4(1):5.
43. Bluyssen HA, Vlietstra RJ, Faber PW, Smit EM, Hagemeijer A, Trap-
man J: Structure, chromosome localization, and regulation of
expression of the interferon-regulated mouse Ifi54/Ifi56 gene
family.  Genomics 1994, 24(1):137-148.
44. Gilly M, Damore MA, Wall R: A promoter ISRE and dual 5' YY1
motifs control IFN-gamma induction of the IRG-47 G-pro-
tein gene.  Gene 1996, 179(2):237-244.
45. Carlow DA, Teh SJ, Teh HS: Specific antiviral activity demon-
strated by TGTP, a member of a new family of interferon-
induced GTPases.  J Immunol 1998, 161(5):2348-2355.
46. Olszewski MA, Gray J, Vestal DJ: In silico genomic analysis of the
human and murine guanylate-binding protein (GBP) gene
clusters.  J Interferon Cytokine Res 2006, 26(5):328-352.
47. Sorace JM, Johnson RJ, Howard DL, Drysdale BE: Identification of
an endotoxin and IFN-inducible cDNA: possible identifica-
tion of a novel protein family.  J Leukoc Biol 1995, 58(4):477-484.
48. Leaman DW, Chawla-Sarkar M, Jacobs B, Vyas K, Sun Y, Ozdemir A,
Yi T, Williams BR, Borden EC: Novel growth and death related
interferon-stimulated genes (ISGs) in melanoma: greater
potency of IFN-beta compared with IFN-alpha2.  J Interferon
Cytokine Res 2003, 23(12):745-756.
49. Chin KC, Cresswell P: Viperin (cig5), an IFN-inducible antiviral
protein directly induced by human cytomegalovirus.  Proc Natl
Acad Sci U S A 2001, 98(26):15125-15130.
50. Honda K, Yanai H, Takaoka A, Taniguchi T: Regulation of the type
I IFN induction: a current view.  Int Immunol 2005,
17(11):1367-78. Epub 2005 Oct 7..
51. Taniguchi T, Takaoka A: A weak signal for strong responses:
interferon-alpha/beta revisited.  Nat Rev Mol Cell Biol 2001,
2(5):378-386.
52. Nussbaum JM, Major M, Gunnery S: Transcriptional upregulation
of interferon-induced protein kinase, PKR, in breast cancer.
Cancer Lett 2003, 196(2):207-216.
53. Wathelet MG, Berr PM, Huez GA: Regulation of gene expression
by cytokines and virus in human cells lacking the type-I inter-
feron locus.  Eur J Biochem 1992, 206(3):901-910.
54. de Veer MJ, Holko M, Frevel M, Walker E, Der S, Paranjape JM, Sil-
verman RH, Williams BR: Functional classification of interferon-
stimulated genes identified using microarrays.  J Leukoc Biol
2001, 69(6):912-920.
55. Nakaya T, Sato M, Hata N, Asagiri M, Suemori H, Noguchi S, Tanaka
N, Taniguchi T: Gene induction pathways mediated by distinct
IRFs during viral infection.  Biochem Biophys Res Commun 2001,
283(5):1150-1156.
56. Liu YJ: IPC: professional type 1 interferon-producing cells and
plasmacytoid dendritic cell precursors.  Annu Rev Immunol 2005,
23:275-306.
57. Sen GC, Sarkar SN: The interferon-stimulated genes: targets of
direct signaling by interferons, double-stranded RNA, and
viruses.  Curr Top Microbiol Immunol 2007, 316:233-250.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Genomics 2008, 9:192 http://www.biomedcentral.com/1471-2164/9/192
Page 15 of 15
(page number not for citation purposes)
58. Sung SS, Fu SM, Rose CE Jr., Gaskin F, Ju ST, Beaty SR: A major lung
CD103 (alphaE)-beta7 integrin-positive epithelial dendritic
cell population expressing Langerin and tight junction pro-
teins.  J Immunol 2006, 176(4):2161-2172.
59. Xu H, Dawson R, Forrester JV, Liversidge J: Identification of novel
dendritic cell populations in normal mouse retina.  Invest Oph-
thalmol Vis Sci 2007, 48(4):1701-1710.
60. Karlis J, Penttila I, Tran TB, Jones B, Nobbs S, Zola H, Flesch IE: Char-
acterization of colonic and mesenteric lymph node dendritic
cell subpopulations in a murine adoptive transfer model of
inflammatory bowel disease.  Inflamm Bowel Dis 2004,
10(6):834-847.
61. Chowdhury SR, King DE, Willing BP, Band MR, Beever JE, Lane AB,
Loor JJ, Marini JC, Rund LA, Schook LB, Van Kessel AG, Gaskins HR:
Transcriptome profiling of the small intestinal epithelium in
germfree versus conventional piglets.  BMC Genomics 2007,
8(1):215.
62. Fukushima K, Sasaki I, Ogawa H, Naito H, Funayama Y, Matsuno S:
Colonization of microflora in mice: mucosal defense against
luminal bacteria.  J Gastroenterol 1999, 34(1):54-60.
63. Hill RR, Cowley HM: Effects of bacterial colonization on
mucosal structure of the large bowel of neonatal rats.  Acta
Anat (Basel) 1988, 132(3):230-233.
64. GEO:  [http://www.ncbi.nlm.nih.gov/projects/geo/].
65. Stringfellow DA: Interferon inducers: theory and experimental
application.  In Interferon and Interferon Inducers Edited by: Stringfel-
low DA. New York , Marcel Dekker, Inc.; 1980:145-166. 
66. Tsuchiya B, Sato Y, Montone KT, Nagai T, Kameya T: Four-hour
double staining for in situ hybridization and immunohisto-
chemistry.  Journal of Histotechnology 2000, 23(4):321-325.